Convenio dutasteride y otros
About This Opportunity
Chile contract award (healthcare): Convenio dutasteride y otros. By Chile Mercadopublico. Awarded to EXELTIS CHILE SPA (CLP 65.7M, Apr 2026).
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Chile, Latin America, this opportunity is open to firms and consortiums.
Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
This tender, originating from Chile and published on the mercadopublico platform, seeks to establish a framework agreement for the procurement of Dutasteride and other related pharmaceutical products. The contracting authority is issuing this call for tenders to secure a reliable and consistent supply of these essential medications for public healthcare services.
This procurement process is designed to identify qualified and experienced suppliers capable of meeting the diverse needs of the Chilean healthcare system.
Prospective bidders are expected to demonstrate their capacity to supply high-quality pharmaceutical goods in compliance with stringent regulatory standards. Typical requirements for such a tender include proven experience in the pharmaceutical sector, adherence to Good Manufacturing Practices (GMP), and the ability to provide comprehensive product documentation, including Certificates of Analysis and marketing authorization. Bidders will likely need to submit detailed proposals outlining their product offerings, pricing structures, delivery capabilities, and quality assurance protocols. The framework agreement aims to facilitate efficient and cost-effective procurement of Dutasteride and associated pharmaceuticals over a defined period, ensuring availability for patients and healthcare providers across Chile. Further details on specific product quantities, technical specifications, and evaluation criteria will be provided within the full tender documentation.
Data provenance
This notice is sourced from Chile Mercado Publico and was originally published on March 7, 2026. Last refreshed 1 day ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
Frequently asked questions about this tender
Is this tender still open?
No — the contract has already been awarded to EXELTIS CHILE SPA. The award notice is archived on BidsFactory for transparency and market intelligence.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
EXELTIS CHILE SPA was awarded the contract for CLP 65,740,000. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Chile. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Chile Mercado Publico to access the full notice, required documents, and submission instructions provided by the contracting authority.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.